Lixte Biotechnology Holdings Inc (LIXT)
2.89
+0.01
(+0.27%)
USD |
NASDAQ |
May 03, 16:00
2.91
+0.02
(+0.69%)
Pre-Market: 09:02
Lixte Biotechnology Holdings 1 Year Total Returns (Daily): -47.55% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -47.55% |
May 02, 2024 | -48.90% |
May 01, 2024 | -48.57% |
April 30, 2024 | -50.80% |
April 29, 2024 | -44.03% |
April 26, 2024 | -42.32% |
April 25, 2024 | -47.21% |
April 24, 2024 | -47.60% |
April 23, 2024 | -51.06% |
April 22, 2024 | -49.09% |
April 19, 2024 | -47.34% |
April 18, 2024 | -50.79% |
April 17, 2024 | -50.99% |
April 16, 2024 | -44.46% |
April 15, 2024 | -47.64% |
April 12, 2024 | -49.57% |
April 11, 2024 | -60.41% |
April 10, 2024 | -63.21% |
April 09, 2024 | -64.02% |
April 08, 2024 | -64.02% |
April 05, 2024 | -65.10% |
April 04, 2024 | -62.41% |
April 03, 2024 | -63.53% |
April 02, 2024 | -55.28% |
April 01, 2024 | -56.85% |
Date | Value |
---|---|
March 28, 2024 | -57.22% |
March 27, 2024 | -58.10% |
March 26, 2024 | -73.53% |
March 25, 2024 | -73.53% |
March 22, 2024 | -70.81% |
March 21, 2024 | -69.97% |
March 20, 2024 | -66.03% |
March 19, 2024 | -64.14% |
March 18, 2024 | -61.80% |
March 15, 2024 | -66.18% |
March 14, 2024 | -67.58% |
March 13, 2024 | -66.62% |
March 12, 2024 | -66.99% |
March 11, 2024 | -64.93% |
March 08, 2024 | -69.27% |
March 07, 2024 | -68.64% |
March 06, 2024 | -68.97% |
March 05, 2024 | -70.31% |
March 04, 2024 | -70.13% |
March 01, 2024 | -70.32% |
February 29, 2024 | -71.35% |
February 28, 2024 | -70.30% |
February 27, 2024 | -69.48% |
February 26, 2024 | -73.68% |
February 23, 2024 | -75.03% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-88.84%
Minimum
Feb 07 2024
746.2%
Maximum
May 28 2019
-15.45%
Average
-44.63%
Median
Jun 14 2021
1 Year Total Returns (Daily) Benchmarks
iBio Inc | -90.87% |
PAVmed Inc | -73.54% |
PDS Biotechnology Corp | -39.17% |
Moleculin Biotech Inc | -56.25% |
Syros Pharmaceuticals Inc | 71.57% |